MORTALITY BURDEN OF TRANSFUSION DEPENDENCY AND IRON OVERLOAD IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.

被引：0
|
作者：
Arnan, M. [1 ]
Pomares, H. [2 ]
Esteban, L. [3 ]
Alonso, E. [4 ]
Pareja, L. [3 ]
Sanchez-Ortega, I. [2 ]
Fernandez de Sevilla, A. [2 ]
Ribes, J. [3 ]
Duarte, R. [1 ]
机构：
[1] Inst Catala Oncol, Hematol Dept, Lhospitalet De Llobregat, Spain
[2] Hosp Duran & Reynals, Inst Catala Oncol, Hematol Dept, Lhospitalet De Llobregat, Spain
[3] Inst Catala Oncol, Catalan Registry Canc, Lhospitalet De Llobregat, Spain
[4] Hosp Univ Bellvitge, PAtol Dept, Lhospitalet De Llobregat, Spain
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P199
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [41] Guidelines on iron chelation therapy in patients with myelodysplastic syndrome and transfusion iron overload
    Gattermann, N.
    LEUKEMIA RESEARCH, 2007, 31 : S15 - S16
  • [42] LEVELS OF TRANSFUSION BURDEN AND ASSOCIATED COSTS FOR PATIENTS WITH TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES
    DeZern, A. E.
    Binder, G.
    Rizvi, S.
    Corvino, F. A.
    Arikian, S. R.
    Surinach, A.
    Lee, J.
    Smith, B. D.
    HAEMATOLOGICA, 2016, 101 : 245 - 245
  • [43] Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
    Gattermann, Norbert
    LEUKEMIA RESEARCH, 2007, 31 : S10 - S15
  • [44] Retrospective analysis of effects of transfusion status on response to decitabine and survival in patients with myelodysplastic syndromes.
    Kadia, T. M.
    Garcia-Manero, G.
    Kantarjian, H.
    Pemmaraju, N.
    Stein, K.
    Teng, A.
    Cortes, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes
    DeZern, Amy E.
    Binder, Gary
    Rizvi, Syed
    Corvino, Frank A.
    Arikian, Steven R.
    Surinach, Andy
    Lee, Jianyi
    Smith, B. Douglas
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2649 - 2656
  • [46] Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes. A systematic review
    Pinchon, Deborah J.
    Stanworth, Simon J.
    Doree, Carolyn
    Brunskill, Susan
    Norfolk, Derek R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (10) : 671 - 677
  • [47] Iron overload and chelation therapy in myelodysplastic syndromes
    Temraz, Sally
    Santini, Valeria
    Musallam, Khaled
    Taher, Ali
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 91 (01) : 64 - 73
  • [48] Consensus statement on iron overload in myelodysplastic syndromes
    Bennett, John M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (11) : 858 - 861
  • [49] Iron Overload in Myelodysplastic Syndromes: Diagnosis and Management
    List, Alan F.
    CANCER CONTROL, 2010, 17 (01) : 2 - 8
  • [50] Retrospective survey of Japanese patients with transfusion-dependent myelodysplastic syndromes and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
    Takatoku, M.
    Uchiyama, T.
    Okamoto, S.
    Kanakura, Y.
    Sawada, K.
    Tomonaga, M.
    Nakao, S.
    Nakahata, T.
    Harada, M.
    Murate, T.
    Ozawa, K.
    BLOOD, 2006, 108 (11) : 751A - 751A
12345